Bin Cui

Prof. Bin Cui

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2020 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
HSHui Sun
Hui Sun
GCGuannan Cui
Guannan Cui
HSHuijian Shang
Huijian Shang
BCBin Cui
Bin Cui


5 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
BCBin Cui
Bin Cui
YZYuting Zheng
Yuting Zheng
HSHui Sun
Hui Sun
HSHuijian Shang
Huijian Shang
MDMan Du
Man Du
CYCafer Yavuz
Cafer Yavuz
Asymmetric catalysis for enantioselective intramolecular hydroamination of alkenes is a critical method in the construction of enantioenriched nitrogen-containing rings, often prevalent in biologically active compounds and natural products. Herein, we demonstrate a facile enantioselective intramolecular hydroamination of alkenes for the synthesis of chiral pyrrolidine, piperidine, and indoline moieties, using a manganese (II) chiral aprotic cyclic urea catalyst. The cyclic ligand hinders the inversion of the N atom of the urea and effectively discriminate between the enantiomers of substrates. High-resolution mass spectrometry, deuterium labeling experiments, and molecular orbital energy analysis clearly reveal the intermediates and mechanism of the transformation. As a key step, oxygen coordination by chiral aprotic urea presents a robust control over the asymmetric intra-HA reaction through the involvement of a convergent assembly of two vital intermediates (Mn-N and C-Mn-Br), providing access to chiral cyclic amine systems in high yields with excellent enantioselectivity.

1 September 2024 in Current Organic Chemistry
Verified
Journal Article
Closed access
PDF file
MBMengran Bai
Mengran Bai
LZLiyuan Zhang
Liyuan Zhang
LLLu Liu
Lu Liu
CJChenyu Jia
Chenyu Jia
YZYuting Zheng
Yuting Zheng
BCBin Cui
Bin Cui
: Due to the robust electrophilic properties of the trifluoromethyl group (-CF3), its incorporation into organic compounds can markedly alter their ester affinity, stability, bioavailability, and other properties. The trifluoromethylation reaction is currently experiencing rapid advancement, with an expanding array of substrates and the emergence of novel methodologies. Consequently, compounds containing the -CF3 moiety find extensive utility across diverse fields. This article aims to comprehensively review the latest advancements in trifluoromethylation reaction of olefins, aldehydes, and ketones, encompassing nucleophilic trifluoromethylation, electrophilic trifluoromethylation, and radical trifluoromethylation. The discussion includes an exploration of the types and broadening scope of applicable substrates. Furthermore, this article addresses the associated challenges and delineates prospective directions for future developments in trifluoromethyl reaction.

31 July 2025 in Molecules
Verified
Journal Article
Open access
PDF file
GZGuo Zhong
Guo Zhong
JZJiayu Zhou
Jiayu Zhou
BCBin Cui
Bin Cui
HSHui Sun
Hui Sun
The regio- and stereoselective adjacent bifunctionalization of olefins with amine and halogen groups can be effectively accomplished through catalytic haloamination methods. Stereoselective haloamination has emerged as a pivotal methodology for the introduction of halogen functional groups into chiral amines, demonstrating substantial applications in medicinal chemistry and organic synthesis. Since 1999, significant advancements have been achieved in this field, driven by innovations in catalytic systems and methodologies. The stereoselective haloamination of both functionalized and nonfunctionalized alkenes employing chiral catalysts has emerged as a prominent area of research. This review provides a comprehensive overview of the research progress in stereoselective haloamination reactions from 1999 to 2023. It examines the innovations in catalyst design that have facilitated more efficient and selective transformations. The review also analyzes the optimization of reaction conditions, which has been crucial in improving the overall performance and applicability of these reactions. Furthermore, it explores the diverse range of haloamination reactions that have been developed, emphasizing their potential for the synthesis of complex and valuable chemical structures. Additionally, this review offers insightful perspectives on future research directions in stereoselective haloamination reactions.

22 July 2026 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
YWYupeng Wu
Yupeng Wu
SWSiyi Wu
Siyi Wu
XWXin Wang
Xin Wang
HSHui Sun
Hui Sun
BCBin Cui
Bin Cui
Cancer and neurodegenerative disorders remain major public health challenges worldwide. Increasing incidence across age groups, together with persistently high mortality in many settings, contributes to substantial socioeconomic burdens on individuals, families, and healthcare systems. Histone Deacetylases (HDACs) are enzymes that remove acetyl groups from lysine residues on histone tails. As a key post-translational modification, histone deacetylation modulates chromatin organization and gene transcription. In many contexts, HDACmediated deacetylation is associated with increased chromatin compaction, which may limit transcription-factor accessibility and reduce transcriptional output. Beyond chromatin regulation, HDACs have been implicated in cell-cycle progression, apoptosis, inflammation, immune responses, redox homeostasis, and neuronal development. Given their involvement in disease mechanisms, Histone Deacetylase Inhibitors (HDACis) have attracted attention as potential epigenetic therapeutics with pleiotropic effects. By counteracting aberrant deacetylation, HDACis may help restore acetylation-dependent transcriptional programs and reactivate genes implicated in disease. They may also affect dysregulated signaling pathways and have been reported to exhibit antiproliferative, anti-inflammatory, neuroprotective, and anticancer effects. Accumulating preclinical and emerging clinical evidence suggests that HDACis are being evaluated for therapeutic activity in a range of malignant and neurodegenerative diseases. This review summarizes recent advances in HDACis, with emphasis on structural classification, key chemical features, molecular mechanisms, and clinical translation in oncology and neurodegeneration. By integrating these aspects, the article aims to provide a conceptual reference for targeted drug discovery and rational combination strategies for these challenging conditions.